chr3-97768395-C-T

Variant summary

Our verdict is Likely benign.
-4 Likely Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -4 classification points (ACGS-UK Somatic Oncogenicity v2025). B1_Strong

The NM_001278293.3(ARL6):c.123+165C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.782 (AC=118,921) in the gnomAD database across 152,014 control chromosomes, including 46,597 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.83. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★).

Frequency

Genomes: 𝑓 0.78 ( 46597 hom., cov: 33)

Consequence

ARL6
NM_001278293.3 intron

Scores

3

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.340

Publications

3 publications found
Variant links:
Genes affected
ARL6 (HGNC:13210): (ARF like GTPase 6) The protein encoded by this gene belongs to the ARF-like (ADP ribosylation factor-like) sub-family of the ARF family of GTP-binding proteins which are involved in regulation of intracellular traffic. Mutations in this gene are associated with Bardet-Biedl syndrome (BBS). A vision-specific transcript, encoding long isoform BBS3L, has been described (PMID: 20333246). [provided by RefSeq, Apr 2016]
ARL6 Gene-Disease associations (from GenCC):
  • Bardet-Biedl syndrome 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P, Ambry Genetics
  • ciliopathy
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, PanelApp Australia
  • retinitis pigmentosa 55
    Inheritance: AR Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Bardet-Biedl syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001278293.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Likely_benign. The variant received -4 points.

B1High frequency in general population
GnomAD effective popmax AF >1% — B1 stand-alone benign; GnomAD effective popmax AF = 0.83 — exceeds 1% threshold (B1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_001278293.3. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

ARL6 NM_001278293.3
MANE Select
HGVSc / HGVSpc.123+165C>T
Exon rankIntron 2 of 7
intron
Prot: NP_001265222.1UniProt: Q9H0F7-1
ARL6 NM_001323513.2
HGVSc / HGVSpc.123+165C>T
Exon rankIntron 2 of 8
intron
Prot: NP_001310442.1UniProt: Q9H0F7-2
ARL6 NM_032146.5
HGVSc / HGVSpc.123+165C>T
Exon rankIntron 3 of 8
intron
Prot: NP_115522.1UniProt: Q9H0F7-1

Ensembl Transcripts

ARL6 ENST00000463745.6
TSL:2MANE Select
HGVSc / HGVSpc.123+165C>T
Exon rankIntron 2 of 7
intron
Prot: ENSP00000419619.1UniProt: Q9H0F7-1
ARL6 ENST00000493990.5
TSL:1
HGVSc / HGVSpn.123+165C>T
Exon rankIntron 3 of 9
intron
Prot: ENSP00000418057.1UniProt: Q9H0F7-1
ARL6 ENST00000496713.1
TSL:1
HGVSc / HGVSpn.361+165C>T
Exon rankIntron 2 of 6
intron
Prot:

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 4 sources
GnomAD3 genomes
AF: 0.782
AC:118818
Hom:46555
AN:151896
Cov:33
GnomAD4 genome
AF: 0.782
AC:118921
Hom:46597
AN:152014
Cov:33
TOPMed (Bravo)
AF: 0.784
AC:207476
Hom:81547
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.776
AC:54134
Hom:21046
AN:69766
Local & regional cohorts 10 sources
ABraOM SABE-WGS-1171
AF: 0.769
AC:1801
Hom:687
AN:2342
ChinaMAP Phase 1
AF: 0.854
Denmark Genome
AF: 0.703
AC:211
AN:300
GenomeAsia100K
AF: 0.806
AC:2799
AN:3472
Korea4K (4,157 Koreans)
AF: 0.867
AC:6245
AN:7202
Qatari Genome
AF: 0.744
AC:131
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.890
AC:108159
Hom:48218
AN:121484
Turkish Variome
AF: 0.736
AC:1137
Hom:424
AN:1544
UK10K
AF: 0.755
AC:5713
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.862
AC:7725
Hom:3332
AN:8960
Showing 14 sources
Tested, but no data found:GnomAD4 exomeIf GnomAD4 is missing, the position is probably not covered by the project.

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational Scores

AlphaGenome AVI
Benign9.4
BayesDel_noAF
Benign-0.91
CADD
Benign7.4
DANN
Benign0.15
GPN-Star LLR
N/A5.7
GPN-Star score
N/A2.5
Mutation Taster
N/A100/0polymorphism (auto)
PhyloP100
Benign0.34
Showing 8 of 8 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.